Chimeric antigen receptor-modified T cells against several target antigens in multiple myeloma

被引：1
|
作者：
Chang, Lung-Ji [1 ]
Liu, Yuchen [1 ]
Kuo, Hao-Hsiang [1 ]
Tsao, Shih-Ting [1 ]
Moreb, Jan S. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3149
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
    Zhang, Erhao
    Gu, Jieyi
    Xu, Hanmei
    MOLECULAR CANCER, 2018, 17
  • [42] Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
    Pang, Yanyu
    Hou, Xiaoyang
    Yang, Chunsheng
    Liu, Yanqun
    Jiang, Guan
    MOLECULAR CANCER, 2018, 17
  • [43] Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
    Zou, Yixin
    Xu, Wei
    Li, Jianyong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [44] Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
    Yixin Zou
    Wei Xu
    Jianyong Li
    Journal of Hematology & Oncology, 11
  • [45] Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
    Erhao Zhang
    Jieyi Gu
    Hanmei Xu
    Molecular Cancer, 17
  • [46] Chimeric Antigen Receptor T Cells in Myeloma Reply
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    June, Carl H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (02): : 194 - 194
  • [47] PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells
    Wenting Zheng
    Carol E. O’Hear
    Rajshekhar Alli
    Jacob H. Basham
    Hossam A. Abdelsamed
    Lance E. Palmer
    Lindsay L. Jones
    Ben Youngblood
    Terrence L. Geiger
    Leukemia, 2018, 32 : 1157 - 1167
  • [48] PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells
    Zheng, Wenting
    O'Hear, Carol E.
    Alli, Rajshekhar
    Basham, Jacob H.
    Abdelsamed, Hossam A.
    Palmer, Lance E.
    Jones, Lindsay L.
    Youngblood, Ben
    Geiger, Terrence L.
    LEUKEMIA, 2018, 32 (05) : 1157 - 1167
  • [49] Generation of Murine Chimeric Antigen Receptor-Modified T Cells for In Vivo Studies in Syngeneic Tumor Models
    Hosseini, Mina
    Akbari, Behnia
    Shahverdi, Ahmad Reza
    Hadjati, Jamshid
    Faramarzi, Mohammad Ali
    Mirzaei, Hamid Reza
    Yazdi, Mohammad Hossein
    CURRENT PROTOCOLS, 2024, 4 (08):
  • [50] Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
    Beatty, Gregory L.
    O'Hara, Mark
    PHARMACOLOGY & THERAPEUTICS, 2016, 166 : 30 - 39
12345